ELEMENTOS BÁSICOS DEL PROCESO
2. APLICACIÓN DE NORMAS Y REGLAMENTOS El docente:
1. Prehypertensive individuals are at risk of developing left ventricular diastolic dysfunction and left ventricular hypertrophy. They should be closely monitored and early life-style modification is recommended.
2. The influence of altered LV geometry and LV diastolic dysfunction in progression from prehypertension to hypertension as well as their consequences need to be determined in a longitudinal study. The finding may influence future determination of the cut-off point of hypertension.
3. Multicentre large population study is required to determine the risk–benefit of drug treatment of prehypertension.
54
REFERENCES
1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J hypertens . 2004; 22: 11-19.
2. Chobanian AV, Bakris GH, Black HR, Cushman WC, Green LA, Izzo JL, et al.
Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003; 42: 1206-1252.
3. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, et al.
Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol. 2012; 12: 327-340.
4. Xiaofan G, Liling Z, Xingang Z, Jue L, Liqiang Z, Zhaoqing S, et al. Prehypertension:
A Meta-Analysis of the Epidemiology, Risk Factors, and Predictors of Progression.
Tex Heart Inst J. 2011; 38: 643–652.
5. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004; 164: 2126-2134.
6. Isezuo SA, Sabir AA, Ohwovoriole AE, Fasanmade OA. Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. J Hum Hypertens. 2011; 25: 224-230.
7. Ejike CE, Ugwu CE, Ezeanyika LU. Variations in the prevalence of point (pre)hypertension in a Nigerian school-going adolescent population living in a semi-urban and an semi-urban area. BMC Pediatrics. 2010;10: 13. doi: 10.1186/1471-2431-10-13.
8. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, et al.
Residual lifetime risk for developing hypertension in middle-aged women and men:
The Framingham Heart Study. JAMA. 2002; 287: 1003-1010.
55 9. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet . 2001; 358: 1682-1686.
10. Nesbitt SD, Julius S, Leonard D, Egan BM, Grozinski M. Is low-risk hypertension fact or fiction? Cardiovascular risk profile in the TROPHY study. Am J Hypertens.
2005; 18: 980-985.
11. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated Coronary risk profile. A statement for health professionals. Circulation. 1991; 83: 356–362.
12. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913.
13. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Porcellati C.
Prevalence and determinants of left ventricular filling abnormalities in an unselected hypertensive population. Eur Heart J. 1990; 11: 679-691.
14. Aeschbacher BC, Hutter D, Fuhrer J, Weidmann P, Delacrétaz E, Allemann Y.
Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens. 2001; 14: 106-113.
15. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA. 1996; 275: 1571-1576.
16. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KL. The progression from hypertension to congestive heart failure, JAMA. 1996; 275: 1556-1562
17. Gandhi SK, Powers JC, Nomeir AM, Fowler K.,Kitzman DW, Rankin KM, et al. The pathogenesis of acute pulmonary oedema associated with hypertension. N Engl J Med. 2001 ;344: 17-22.
56 18. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammed Y. Is prehypertension a
risk factor for cardiovascular disease? Stroke. 2005; 36; 1859-1862.
19. Mainous AG, Everett CJ, Liszka H, King DE, Egan BM. Prehypertension and mortality in a nationally representative cohort. Amer J Cardiol. 2004: 94; 1496-1500.
20. Cordero A, Laclaustre M, Leon M, Grima A, Casasnovas JA, Luengo E, et al.
Prehypertension is associated with insulin resistance state and not with an initial renal function impairment: a metabolic syndrome in active patient in Spain (MESYAS) Registry substudy. Am J Hypertens. 2006; 19: 189-196.
21. Ahn HS, Kim SJ, Kim MK, Choue CW, Kim KS, Song J, et al . The difference of left ventricular hypertrophy and the diastolic function between prehypertensives and normotensives. Korean Circ. J. 2006; 36: 437-442.
22. Erdogan D, Caliskan M, Yildirim I, Gullu H, Baycan S, Ciftci O, et al. Effects of normal blood pressure, prehypertension and hypertension on left ventricular diastolic function and aortic elastic properties. Blood pressure. 2007; 16: 114-121.
23. Dogru MT, Güneri M, Tireli E, Sahin O, Celik T, Iyisoy A. QT interval and dispersion differences between normal and prehypertensive patients: effects of autonomic and left ventricular functional and structural changes. Anadolu Kardiyol.
Derg. 2009; 9: 15-22.
24. Kyung-Soon H. Prehypertension. Korean Circ. J. 2008; 38: 1-6.
25. Markus MR, Stritzke J, Lieb W, Mayer B, Luchner A, Döring A, et al. Implications of persistent prehypertension for age-related changes in left ventricular geometry and function: The MONICA/KORA Augsburg study. J Hypertens. 2008; 26: 2040-2049.
26. Robinson SC, Brucer M. Range or normal blood pressure: A statistical and clinical study of 11,383 persons. Arch Intern Med. 1939; 64: 409-444.
57 27. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States,1999-2000. Arch Intern Med. 2004; 164: 2113-2118.
28. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertensive status and inflammatory markers related to atherosclerotic disease: the ATTICA study. Am J Hypertens. 2004; 17: 568-573 .
29. Ferguson TS, Younger NO, Tulloch-Reid MK, Wright MB, Ward EM, Ashley DE, et al. Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: Analysis from a cross-sectional survey. BMC Cardiovasc Disord.
2008; 8: 20. doi: 10.1186/1471-2261-8-20.
30. Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults:
Trabzon Hypertension Study. J Public Health (Oxf.). 2009; 31: 47-58.
31. Choi M, Park HS, Han JH, Lee JS, Lee J, Ryu OH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. Journal of Hypertension. 2006; 24: 1515–1521.
32. Ishikawa Y, Ishikawa J, Ishikawa S., Kayaba K, Nakamura Y, Shimada K, et al.
Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School cohort study. Hypertension Research. 2008; 31: 1323–1330.
33. Yang J, Lu F, Zhang C, Liu Z, Zhao Y, Gao F, et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertension Research.
2010; 33: 331–337.
34. Agyemang C, Owusu-Dabo E. Prehypertension in the Ashanti region of Ghana, West Africa: an opportunity for early prevention of clinical hypertension. Public Health.
2008; 122: 19-24.
58 35. Nwankwo EA, Ene AC, Nwankwo BB. Prevalence of prehypertension, hypertension and high body mass index in newly presenting diabetics in sub-Saharan Africa. The Internet Journal of Tropical Medicine. 2008; 5: 1-6.
36. Wu SL, Zhang ZQ, Song SB, Yao TC, Li Y, Wang JL, et al. Prevalence of prehypertension and associated cardiovascular risk: two years follow up results.
Chinese Journal of Epidemiology. 2010; 38: 415-419.
37. Tsai PS, Ke TI, Huang CJ, Tsai JC, Chen PL, Wang SY, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens. 2005; 23: 1355-1360.
38. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, et al. Prehypertension, diabetes and cardiovascular disease risk in a population-based sample. Hypertension.
2006; 47: 410-414.
39. Okosun IS, Boltri JM, Anochie LK, Chandra K. Racial/Ethnic differences in prehypertension in American Adults: Population and relative attributable risk of abdominal obesity. J Hum Hypertens. 2004; 18: 849-855.
40. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension.
2006; 48: 254-259.
41. Nimoniya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, et al.
Prehypertension increases the risk of renal arteriosclerosis in autopsies: the Hisayama Study. J Am Soc Nephrol. 2007; 18: 2135-2142.
42. Tomiyama H, Matsumoto C, Yamada J, Yoshida J, Yoshida M, Odaira M, et al.
Predictors of progression from prehypertension to hypertension in Japanese men. Am J Hypertens. 2009; 22: 630-636.
59 43. Player MS, King DE, Mainous AG, Geesey ME. Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease. Ann Fam Med. 2007; 5: 403-411.
44. Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM.
Progression is accelerated from prehypertension to hypertension in Blacks.
Hypertension. 2011; 58: 579-587.
45. Bakx JC, Van den Hoogen HJ, Van den Bosch WJ, Van Schayek CP, Van Ree JW, Thien T, et al. Development of blood pressure and the incidence of hypertension in men and women over an 18-year period: results of the Nijmegen cohort study. J Clin Epidemiol. 1999; 52: 531-538.
46. Wright MBL, Devereux RB, Roman JR, Chinali M, Best LG, Galloway J, et al.
Association of prehypertension by joint national committee 7 criteria with left ventricular structure and function; the strong heart study. J Am Coll Cardiol. 2004;
17: 1142-1183.
47. Kim SH, Cho GY, Baik I, Lim SY, Choi CU, Lim HE, et al. Early Abnormalities of cardiovascular structure and function in middle-aged Korean adults with prehypertension: The Korean Genome Epidemiology Study. Am J Hypertens. 2011;
24: 218-224.
48. Di Bello V, Talini E, Dell-Omo G, Giamini C, Delle-Donne MG, Canale ML, et al.
Early left ventricular mechanics abnormalities in prehypertension: a two- dimensional strain echocardiography study. Am J Hypertens. 2010; 23: 405-412.
49. Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of prehypertension in youth. J Clin Hypertens (Greenwich).
2011; 13: 332-342.
60 50. Zhu H, Yan W, Ge D, Treiber FA, Harshfield GA, Kapuku G, et al. Cardiovascular characteristics in American youth with prehypertension. Am J Hypertens. 2007; 20:
1051-1057.
51. Mittal SR. LV remodelling and / or diastolic dysfunction in normal persons with BP of 120 / 80 mm Hg or less and no other cardiovascular risk factors. J Ass Phys India.
2012; 60: 18-20.
52. Ale OK, Ajuluchukwu JN, Oke DA, Mbakwem AC. Impact of prehypertension on left ventricular mass QT dispersion in adult black Nigerians. Cardiovasc J Afr. 2014;25:
78-82.
53. Adamu UG, Kolo PM, Katibi IA, Opadijo GO, Omotosho AB, Araoye MA.
Relationship between left ventricular diastolic function and geometric patterns in Nigerians with newly diagnosed systemic hypertension. Cardiovasc J Afr. 2009; 20:
173–177.
54. Aje A, Adebiyi AA, Oladapo OO, Dada A, Ogah OS, Ojji DB, et al. Left ventricular geometric patterns in newly presenting Nigerian hypertensives: An echocardiographic study. BMC Cardiovascular Disorders 2006; 6: 4. doi: 10.1186/1471-2261-6-4.
55. Muhammad SI, Garko SB, Oyati AI, Danbauchi SS. Patterns of left ventricular hypertrophy and geometry in newly diagnosed hypertensive adults in Northern Nigerians. J. Diabetes Endocrinol. 2010; 1: 1-5.
56. Talle MA, Okeahialam BN, Bakki B, Anjorin CO, Baba MM, Goni BW, et al. Left ventricular geometry in untreated hypertensive patients presenting to a tertiary hospital in North Eastern Nigeria. BOMJ. 2011; 8: 20-25.
57. Adebayo RA, Bamikole OJ, Balogun MO, Akintomide AO, Adeyeye VO, Bisiriyu LA, et al. Echocardiographic Assessment of Left Ventricular Geometric Patterns in Hypertensive Patients in Nigeria. Clin Med Insights Cardiol. 2013; 7: 161–167.
61 58. Akintunde A, Akinwusi O, Opadijo GO. Left ventricular hypertrophy, geometric patterns and clinical correlates among treated hypertensive Nigerians. Pan Afr Med J.
2010; 4: 8-10.
59. Adebayo AK, Oladapo OO, Adebiyi AA, Ogunleye OO, Ogah OS, Ojji DB, et al.
Changes in left atrial dimension and function and left ventricular geometry in newly diagnosed untreated hypertensive subject. J Cardiovasc. Med (Hagerstown). 2008; 6:
561-569.
60. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al.
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25:
1105-1187.
61. Karanja NM, Obarzanek E, Lin PH, McCullough ML, Phillips KM, Swain JF, et al.
Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc.
1999; 99: 19-27.
62. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med. 1997; 336: 1117–1124.
63. Cocco G, Pandolfi S. Physical exercise with weight reduction lowers blood pressure and improves abnormal left ventricular relaxation in pharmacologically treated hypertensive patients. J Clin Hypertens. 2011; 13: 23–29.
64. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. 2000;
35: 544-549.
62 65. Funk KL, Elmer PJ, Stevens VJ, Harsha DW, Craddick SR, Lin PH, et al.
PREMIER—A trial of lifestyle interventions for blood pressure control: Intervention design and rationale. Health Promot Pract. 2008; 9: 271–280.
66. Kelley A, Kelley KS. Progressive resistance exercise and resting blood pressure: a meta- analysis of randomized controlled trials. Hypertension. 2000; 35: 838–843.
67. Whelton P, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002; 136: 493–503.
68. Marmot MG, Elliott P, Shipley MJ, Dyer AR, Ueshima H, Beevers DG, et al.
Alcohol and blood pressure: The INTERSALT study. BMJ. 1994; 308: 1263–1267.
69. Puddey B, Beilin LJ. Alcohol is bad for blood pressure: Clin Exp Pharmacol Physiol.
2006; 33: 847–852.
70. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al.
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354: 1685-1697.
71. Cadée JA, Chang CY, Chen CW, Huang CN, Chen SL, Wang CK. Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects. Am J Hypertens. 2007; 20: 1-5.
72. Fuchs FD. Prehypertension: the rationale for early drug therapy. Cardiovasc Ther.
2010; 28: 339-343.
73. Oyejide CO: Health research methods for developing country scientists. 1st Ed. Codat publications, Ibadan 2005; pp 59-63.
74. Ibrahim T: Research methodology and dissertation writing for health and allied professionals. 1st Ed. Cress global link LTD, Abuja 2009; pp 74-75.
75. Lorell BH, Carabello BA. Left Ventricular hypertrophy: pathogenesis, detection and prognosis. Circulation. 2000; 102: 470-479.
63 76. Kollof MH. Critical care parameters and formulas. In: Cooper DH, Krank AJ, Reno HEL. Washington Manual of Medical Therapeutics. 29th edition. Philadelphia USA;
Lippincott Williams and Wilkins 2001; pp 31.
77. Mason JW, Hancock EW, Gettes L. A scientific statement from the American Heart Association electrocardiography and arrhythmias committee, council on clinical cardiology; the American College of Cardiology Foundation: and Heart Rhythm Society. Part II: Electrocardiography diagnostic statement list. Circulation. 2007; 115:
1325-1332.
78. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial leads. Am Heart J. 1949; 37: 161-168.
79. Cheithin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA guidelines for the clinical application of echocardiography: A report of the American College of Cardiology/American Heart Association. Task force on practice guidelines (Committee on Clinical Application of Echocardiography) developed in collaboration with the American Society of Echocardiography.
Circulation. 1997; 95: 1686-1744.
80. Levy D, Savage DD, Garrison R, Anderson KM, Kannel WB, Castelli WP:
Echocardiographic criteria for LVH: The Framingham Heart Study. Am J Cardiol.
1987; 59: 956-960.
81. Armstrong WF, Ryan T. Feigenbaum’s Echocardiography. 7th Ed. 2010; 7: 159-183.
82. Otto CM. Echocardiographic evaluation of left and right ventricular systolic function.
In: Otto CM editor. Textbook of Clinical Echocardiography. 2nd edition.
Philadelphia: W.B. Saunders; 2000.pp. 100-129.
64 83. Sotonye TD, Maclean RA, Osaretin JO. Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria. Vasc. Health Risk Manag. 2013; 9: 529-533.
84. World Health Organisation. Diet, Nutrition and prevention of chronic diseases. 2003.
Geneva. WHO.
85. Registrar General of Great Britain Classification. David Blane. Inequality of social class. In: Patrick DL, Scrambler G. editors. Sociology as applied to medicine. London Philadelphia, Toronto. Bailliere Tindall. 1982:114 – 124.
86. Drukteinis JS, Roman MJ, Fabsitz RR, Lee ET, Best LG, Russell M et al. Cardiac and systemic haemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the strong heart study. Circulation. 2007; 115: 221-227.
87. Chi-Hsuan Y, Jui-Peng T, Yih-Jer W, Jen-Yuan K, Hung-I Y, Charles JH et al.
Change of body surface electrocardiogram is linked to left ventricular geometric alteration from normal, prehypertension to hypertension: comparison of NT-ProBNP and hs-CRP in determining ventricular remodelling. Hypertension. 2011; 27: 29-37.
88. Saidu H, Karaye MK, Okeahialam BN. Plasma lipid profile in Nigerians with high-normal blood pressure. BMC Research Notes. 2014; 7: 930. doi:10.1186/1756-0500-7-930.
89. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for association of high blood pressure and hyperinsulinaemia in obese men. J Clin Endocrinol Metab. 1986; 62: 1302-1304.
90. Zuoguang W, Xiaoyun P, Yanduo T, Ya L, Jieling L, Xingjun C et al. Is prehypertension really different from normotension and hypertension? A case control pilot proteomic study in Chinese. Clinical and experimental hypertension. 2009; 31:
316-329.
65 91. Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE et al. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension 2009: 53; 28-34.
92. Santos AB, Gupta DK, Bello NA, Gori M, Claggett B, Fuchs FD et al.
Prehypertension is associated with abnormalities of cardiac structure and function in the Atherosclerosis Risk in Communities Study. Am J Hypertens. 2015. Sept 7. doi:
10.1093/ajh/hpv/156.
93. Mayet J, Shahi M, Foale RA, Poulter NR, Server PS, McG Thom SA. Racial differences in cardiac structure and function in essential hypertension. Br Med J.
1994; 308: 1011-1014.
94. Saidu H, Karaye MK, Okeahialam BN. Pattern of left ventricular geometry in Nigerians with prehypertension. Nig J Cardiol. 2016.13:18-22.
95. Buono F, Crispo S, Pagano G, Rengo G, Petitto M, Trimarco B et al. Determinants of left ventricular hypertrophy in patients with recent diagnosis of essential hypertension. J.Hypertens. 2014; 32: 166-173.
96. Nagueh SF, Appleton CP, Gilbert TC, Marino PN, Oh JK, Smiseth OA, et al.
Recommendation for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2008; 22: 107-133.
97. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al.
Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000; 102: 1788–1794.
98. Maggio AB, Aggoun Y, Marchand LM, Martin XE, Herrmann F, Beghetti M, et al.
Associations among obesity, blood pressure, and left ventricular mass. J Pediatr.
2008; 152: 489–493.
66
APPENDICES
APPENDIX 1: Consent Form